x

Akebia Therapeutics, Inc. (Nasdaq:AKBA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1517022
Company

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Address
245 First Street
Suite 1400
Cambridge, Massachusetts 02142
Employees
205
Stock Info
Close
$1.6000
Day Range
1.5800 - 1.6591
52 Week Range
0.4901 - 1.8400
Average volume
1.96M
Short Interest
8M (02/15/24)
% of Float Shorted
4.83%
Market Cap
$305.19M
Revenue
$292.48M
Net Income
-$94.23M
2020 Sales Growth
N/A
Rev. per Employee
$944.44K
P/E Ratio
N/A
EPS
-$0.3287
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
John P Butler MBA
Chairman
Adrian Adams
Independent Director
LeAnne M Zumwalt
Independent Director
Ronald E Frieson MBA
Independent Director
Myles Wolf MD
Independent Director
Steven C Gilman PhD
Independent Director
Michael W Rogers MBA
Independent Director
Cynthia Smith MBA
SEC filings
DateFormEvent
16 Oct, 2024 8-K
12 Sep, 2024 EFFECT
10 Sep, 2024 CORRESP
9 Sep, 2024 UPLOAD
3 Sep, 2024 S-3
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
11 Jul, 2024 8-K
2 Jul, 2024 4
26 Jun, 2024 3
24 Jun, 2024 8-K
10 Jun, 2024 8-K
10 Jun, 2024 4
10 Jun, 2024 4
10 Jun, 2024 4
10 Jun, 2024 4
10 Jun, 2024 4
10 Jun, 2024 4
10 Jun, 2024 4
14 May, 2024 4
14 May, 2024 4
13 May, 2024 144
13 May, 2024 144
9 May, 2024 8-K
9 May, 2024 10-Q
9 May, 2024 4
25 Apr, 2024 DEFA14A
25 Apr, 2024 ARS
25 Apr, 2024 DEF 14A
23 Apr, 2024 8-K
16 Apr, 2024 8-K
28 Mar, 2024 8-K
15 Mar, 2024 8-K CEO Change
14 Mar, 2024 10-K
14 Mar, 2024 8-K
1 Mar, 2024 4
1 Mar, 2024 4
1 Mar, 2024 4
1 Mar, 2024 4
29 Feb, 2024 4
29 Feb, 2024 144
29 Feb, 2024 144
29 Feb, 2024 144
29 Feb, 2024 144
29 Feb, 2024 4
29 Feb, 2024 4
29 Feb, 2024 4
27 Feb, 2024 144
27 Feb, 2024 144
27 Feb, 2024 144
27 Feb, 2024 144
13 Feb, 2024 8-K
13 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
2 Feb, 2024 4
2 Feb, 2024 4
2 Feb, 2024 4
2 Feb, 2024 4
2 Feb, 2024 4
2 Feb, 2024 4
2 Feb, 2024 4
1 Feb, 2024 144
1 Feb, 2024 144
30 Jan, 2024 S-8
30 Jan, 2024 8-K
18 Jan, 2024 3
18 Jan, 2024 3
8 Jan, 2024 8-K
8 Jan, 2024 8-K
18 Dec, 2023 8-K
21 Nov, 2023 8-K
8 Nov, 2023 10-Q
8 Nov, 2023 8-K
2 Nov, 2023 8-K
25 Oct, 2023 8-K
12 Oct, 2023 8-K
26 Sep, 2023 8-K
28 Aug, 2023 10-K/A
28 Aug, 2023 10-Q
25 Aug, 2023 8-K
17 Aug, 2023 8-K
11 Aug, 2023 8-K
10 Aug, 2023 NT 10-Q
1 Aug, 2023 8-K
1 Aug, 2023 4
18 Jul, 2023 3
18 Jul, 2023 8-K
13 Jun, 2023 8-K CEO Change
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 8-K
8 Jun, 2023 4
7 Jun, 2023 8-K
6 Jun, 2023 S-8
2 Jun, 2023 8-K
31 May, 2023 8-K
30 May, 2023 8-K
25 May, 2023 144
25 May, 2023 4
25 May, 2023 144
25 May, 2023 8-K
25 May, 2023 4
23 May, 2023 8-K
18 May, 2023 4
18 May, 2023 4
16 May, 2023 144
16 May, 2023 144
16 May, 2023 4
16 May, 2023 4
9 May, 2023 8-K
8 May, 2023 8-K
8 May, 2023 8-K
8 May, 2023 10-Q
28 Apr, 2023 DEF 14A
28 Apr, 2023 8-K
28 Apr, 2023 ARS
25 Apr, 2023 8-K
21 Apr, 2023 DEFA14A
14 Apr, 2023 DEFA14A
14 Apr, 2023 DEFA14A
11 Apr, 2023 DEFA14A
11 Apr, 2023 8-K
31 Mar, 2023 DEFA14A
27 Mar, 2023 DEFA14A
27 Mar, 2023 DEFA14A
27 Mar, 2023 DEFA14A
24 Mar, 2023 DEFA14A
17 Mar, 2023 DEFR14A
10 Mar, 2023 10-K
9 Mar, 2023 8-K
3 Mar, 2023 4
3 Mar, 2023 4
3 Mar, 2023 4
3 Mar, 2023 4
3 Mar, 2023 4
2 Mar, 2023 8-K
1 Mar, 2023 4
1 Mar, 2023 4
1 Mar, 2023 4
1 Mar, 2023 4
1 Mar, 2023 4
1 Mar, 2023 DEF 14A
21 Feb, 2023 8-K
17 Feb, 2023 PRE 14A
10 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
2 Feb, 2023 4
2 Feb, 2023 4
2 Feb, 2023 4
30 Jan, 2023 S-8
20 Jan, 2023 SC 13G/A
9 Jan, 2023 8-K
28 Dec, 2022 8-K
19 Dec, 2022 SC 13G
15 Dec, 2022 8-K
13 Dec, 2022 CT ORDER
10 Nov, 2022 8-K
8 Nov, 2022 8-K
3 Nov, 2022 8-K
3 Nov, 2022 10-Q
7 Oct, 2022 CT ORDER
1 Sep, 2022 4
4 Aug, 2022 10-Q
4 Aug, 2022 8-K
18 Jul, 2022 8-K
8 Jul, 2022 SC 13G
30 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 8-K
9 Jun, 2022 4
9 Jun, 2022 SC 13G/A
9 Jun, 2022 4
9 Jun, 2022 4
9 Jun, 2022 4
9 Jun, 2022 4
9 Jun, 2022 4
9 Jun, 2022 4
7 Jun, 2022 4
16 May, 2022 4
16 May, 2022 4
13 May, 2022 8-K
9 May, 2022 10-Q
9 May, 2022 8-K
28 Apr, 2022 DEF 14A
28 Apr, 2022 EFFECT
28 Apr, 2022 DEFA14A
7 Apr, 2022 8-K
7 Apr, 2022 424B5
7 Apr, 2022 424B5
7 Apr, 2022 8-K
30 Mar, 2022 8-K
18 Mar, 2022 CT ORDER
2 Mar, 2022 4
2 Mar, 2022 4
2 Mar, 2022 4
2 Mar, 2022 4
2 Mar, 2022 4
2 Mar, 2022 4
2 Mar, 2022 4
1 Mar, 2022 10-K
1 Mar, 2022 8-K
1 Mar, 2022 POSASR
1 Mar, 2022 POS AM
22 Feb, 2022 8-K
18 Feb, 2022 4/A
10 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
7 Feb, 2022 SC 13G/A
28 Jan, 2022 S-8
24 Jan, 2022 8-K
5 Jan, 2022 4
30 Dec, 2021 CT ORDER
15 Dec, 2021 8-K/A
4 Nov, 2021 8-K
4 Nov, 2021 10-Q
3 Nov, 2021 4
3 Nov, 2021 3
1 Nov, 2021 8-K
1 Oct, 2021 4
28 Sep, 2021 8-K
9 Sep, 2021 8-K
2 Sep, 2021 4
24 Aug, 2021 8-K
10 Aug, 2021 SC 13G/A
5 Aug, 2021 10-Q
5 Aug, 2021 8-K
12 Jul, 2021 SC 13G/A
9 Jun, 2021 4
3 Jun, 2021 4
3 Jun, 2021 4
3 Jun, 2021 4
3 Jun, 2021 8-K
3 Jun, 2021 4
3 Jun, 2021 4
3 Jun, 2021 4
1 Jun, 2021 8-K
10 May, 2021 10-Q
10 May, 2021 8-K
22 Apr, 2021 DEF 14A
22 Apr, 2021 DEFA14A
1 Apr, 2021 4
1 Apr, 2021 4
1 Apr, 2021 4
1 Apr, 2021 4
1 Apr, 2021 4
1 Apr, 2021 4
30 Mar, 2021 8-K
18 Mar, 2021 4
18 Mar, 2021 4
18 Mar, 2021 4
18 Mar, 2021 4
18 Mar, 2021 4
18 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
2 Mar, 2021 4
25 Feb, 2021 S-3ASR
25 Feb, 2021 8-K
25 Feb, 2021 10-K
18 Feb, 2021 4
18 Feb, 2021 8-K
18 Feb, 2021 3
17 Feb, 2021 8-K
12 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G
10 Feb, 2021 SC 13G
10 Feb, 2021 SC 13G/A
3 Feb, 2021 SC 13G/A
29 Jan, 2021 SC 13G/A
28 Jan, 2021 8-K
28 Jan, 2021 3
22 Jan, 2021 S-8
12 Jan, 2021 8-K
Last update:2024-03-06 12:26:12.922766

Sign Up to Subscribe